Extending the term of exclusive access to clinical trial data will raise drug costs in the short term but also help approve 200 extra drugs and result in greater life expectancy in the long term, ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Revolutionary AI assistant RISA eliminates the pain of hunting for patient data across multiple systems, enabling clinicians to focus more on patient care ThetaRho.ai, a provider of AI-powered ...
NEW YORK, Dec 4 (Reuters) - Global drugmaker Pfizer Inc will broaden access to information from its scores of clinical trials to independent researchers and to patients who take part in the studies, ...
The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found ...
New functionality within Counterpart Assistant uses Google Cloud’s Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data WILMINGTON, Del., March 03, ...
Structure Therapeutics (GPCR) announced positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living ...
New data shows that China and the US dominate breast cancer clinical trial expertise while lower-income countries remain ...
WILMINGTON, Del., March 03, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a leading AI-powered physician enablement platform, today announced it has partnered with Google Cloud to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback